Gisele Dion

Gisele Dion currently serves as the Chief Accounting Officer at Alnylam Pharmaceuticals, a position held since September 2023. Additionally, Gisele serves as an Independent Director and Audit Committee Chair for both Inhibikase Therapeutics, Inc. and Cytek Biosciences. Previous roles include Senior Advisor to the CFO at Takeda, where Gisele contributed to accounting integration efforts following the acquisition of Shire Pharmaceuticals, and a Senior Vice President and Chief Accounting Officer at both Shire and Takeda, overseeing corporate reporting and financial compliance. Earlier experience includes leadership roles at Biogen Idec, Raytheon, Eastman Kodak, and Old Mutual, along with foundational work at FASB. Gisele holds a Bachelor of Science in Accounting and Management Information Systems from Fairfield University and completed the Women on Boards executive program at Harvard Business School.